Figure 2
Pattern of HCV RNA, alanine aminotransferase, and CD19 mean values of the 19 patients with HCV-positive MC during the study. RTX indicates rituximab infusions; EOT, end of treatment; and ALT, alanine aminotransferase.
Pattern of HCV RNA, alanine aminotransferase, and CD19 mean values of the 19 patients with HCV-positive MC during the study. RTX indicates rituximab infusions; EOT, end of treatment; and ALT, alanine aminotransferase.
